Xeris Biopharma Holdings Inc (XERS)
Operating Income Growth
15.42%
Quarterly · Period ending:
XERS Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported15.42%period ending
Latest reported15.42%period ending
XERS Quarterly Operating Income YoY % (-152.31% → 15.42%)
Year-over-year change
High-resolution chart · PNG
XERS operating income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income Growth |
|---|---|
| 15.4172% | |
| 356.1812% | |
| 898.9875% | |
| 152.2066% | |
| 154.7453% | |
| 78.3082% | |
| 117.0613% | |
| -162.4262% | |
| 48.764% | |
| -7.2908% | |
| 35.1285% | |
| 73.8392% | |
| 15.5265% | |
| 54.3338% | |
| 68.5733% | |
| 22.9001% | |
| 26.6452% | |
| -73.6798% | |
| -149.5528% | |
| -77.2264% | |
| -16.1315% | |
| 40.7518% | |
| 41.0292% | |
| 54.3115% | |
| 34.8062% | |
| -11.0744% | |
| -61.4699% | |
| -101.3117% | |
| -175.6332% | |
| -116.8542% | |
| -120.5886% | |
| -97.3455% | |
| -137.6803% | |
| -152.3123% |